People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

People take GLP-1 drugs like Wegovy, Ozempic, Mounjaro, and Zepbound for a variety of reasons, from controlling diabetes and sleep apnea to managing weight and enjoying benefits to the heart, liver, ...

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a yearlong campaign to stop independent labs from producing cheaper versions. Former Novo Nordisk CEO ...

One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other heart problems.

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, ...

GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness ...

A new study suggests heart health gains disappear in half the time it takes to build them up when people stop taking GLP-1 ...

GLP-1 receptor agonists were associated with reduced risk of alcohol, cannabis, cocaine, nicotine and opioid use disorders, as well as other substance use disorders, suggesting potential prevention ...

Frozen pizzas were always seen as quick foods rather than wholesale, well-rounded meals... until now. Nestlé has helped ...

This experimental pill helped people lose about 16% of their body weight after about a year of treatment ...

Clinical and payer strategies should treat GLP‑1 therapy as chronic for high-risk patients, addressing tolerability and cost ...